Peer review reports
From: Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
| Original Submission | ||
|---|---|---|
| 14 Aug 2022 | Submitted | Original manuscript |
| 25 Aug 2022 | Reviewed | Reviewer Report - Takao Takeshima |
| 29 Aug 2022 | Reviewed | Reviewer Report |
| 11 Sep 2022 | Author responded | Author comments - Giorgio Lambru |
| Resubmission - Version 2 | ||
| 11 Sep 2022 | Submitted | Manuscript version 2 |
| Publishing | ||
| 12 Sep 2022 | Editorially accepted | |
| 4 Nov 2022 | Article published | 10.1186/s10194-022-01507-8 |